Wheeler Bio is a biotechnology startup that operates in the pharmaceutical industry, specifically in the field of biologics drug development. The company's primary goal is to streamline and expedite the process of drug discovery to Investigational New Drug (IND) application, a critical regulatory step in the U.S. for testing new drugs in humans. Wheeler Bio serves biopharma companies, Contract Research Organizations (CROs), and Contract Development and Manufacturing Organizations (CDMOs), helping them overcome the common challenges and delays that occur between the discovery and development stages of drug production.

Wheeler Bio's unique business model is based on a partnering approach, fostering shared success and long-term collaborations. The company offers a range of services, including mammalian cell line and process development, Good Laboratory Practice (GLP) toxicology material supply, and efficient clinical supply in compliance with Current Good Manufacturing Practice (CGMP) regulations.

One of Wheeler Bio's key offerings is Portable CMC®, a service designed to simplify the connection between drug discovery and clinical supply. This service standardizes and democratizes the pathway from innovation to first-in-human clinical trials, reducing risk and offering modular work packages to fit various timelines and budgets.

Wheeler Bio generates revenue through its service offerings, charging clients for the development, supply, and testing of materials necessary for drug development and clinical trials. The company is based in Oklahoma City, OK, and is part of the city's growing biomanufacturing ecosystem.

Keywords: Biotechnology, Biopharmaceuticals, Drug Discovery, Drug Development, Contract Research Organizations, Contract Development and Manufacturing Organizations, Mammalian Cell Line Development, Process Development, Clinical Supply, Investigational New Drug Application.